Paper · 42935641
Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040.
Jin X and 4 others. Front Oncol, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040. Papers, record 42935641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42935641
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040.
- Journal
- Front Oncol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 42,636,620 | Burden and future trajectory of pancreatic cancer in the EU-28, 1990-2023: A GBD 2023 analysis with projections to 2050. | Cancer Treat Res Commun | 2026 | https://conductscience.org/library/papers/42636620 | PubMed |
| 2 | 34,216,688 | Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. | Cancer Lett | 2021 | https://conductscience.org/library/papers/34216688 | PubMed |
| 3 | 38,658,636 | The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis. | Sci Rep | 2024 | https://conductscience.org/library/papers/38658636 | PubMed |
| 4 | 32,593,337 | Pancreatic cancer. | Lancet | 2020 | https://conductscience.org/library/papers/32593337 | PubMed |
| 5 | 35,862,875 | Building on More Than 20 Years of Progress in Pancreatic Cancer Surveillance for High-Risk Individuals. | J Clin Oncol | 2022 | https://conductscience.org/library/papers/35862875 | PubMed |
| 6 | 39,475,214 | Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review. | Cancer Biol Med | 2024 | https://conductscience.org/library/papers/39475214 | PubMed |
| 7 | 34,002,083 | Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/34002083 | PubMed |
| 8 | 42,528,617 | Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42528617 | PubMed |
| 9 | 36,804,602 | Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. | Gastroenterology | 2023 | https://conductscience.org/library/papers/36804602 | PubMed |
| 10 | 39,880,919 | The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/39880919 | PubMed |
1 to 10 of 46
See all 46 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42935641
GET https://conductscience.org/api/papers/v1/42935641/references?page=2